Viewing StudyNCT00068757



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00068757
Status: COMPLETED
Last Update Posted: 2012-09-12
First Post: 2003-09-10

Brief Title: Lonafarnib Trastuzumab and Paclitaxel in Treating Patients With HER2Neu-Overexpressing Stage IIIB Stage IIIC or Stage IV Breast Cancer
Sponsor:
Organization: European Organisation for Research and Treatment of Cancer - EORTC

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 23
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: